# Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis

> **NCT01481818** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 15 (estimated)

## Conditions studied

- Epigallocatechin Gallate
- Radio Dermatitis
- Radiation Mucositis

## Interventions

- **DRUG:** EGCG

## Key facts

- **NCT ID:** NCT01481818
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2022-06
- **Final completion:** 2022-08
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481818, "Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01481818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*